Sumatriptan Succinate
These highlights do not include all the information needed to use SUMATRIPTAN INJECTION safely and effectively. See full prescribing information for SUMATRIPTAN INJECTION. SUMATRIPTAN injection, for subcutaneous use Initial U.S. Approval: 1992
Approved
Approval ID
e0917960-87bf-4650-b60b-64bef2ccc4d6
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 26, 2023
Manufacturers
FDA
Wockhardt USA LLC.
DUNS: 170508365
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Sumatriptan Succinate
PRODUCT DETAILS
NDC Product Code64679-728
Application NumberANDA078593
Marketing CategoryC73584
Route of AdministrationSUBCUTANEOUS
Effective DateDecember 26, 2023
Generic NameSumatriptan Succinate
INGREDIENTS (3)
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SUMATRIPTAN SUCCINATEActive
Quantity: 6 mg in 0.5 mL
Code: J8BDZ68989
Classification: ACTIM